The study also revealed the downregulation of two genes, CDK18 and CCND1, in ccRCC blood compared to healthy samples, as well as a tendency towards upregulation for LOX in metastatic compared to non-metastatic ccRCC. The gene discussed is CCND1; the disease is nonpapillary renal cell carcinoma.